Sign in →

Test Code PNTO Streptococcus pneumoniae IgG Antibodies, Total, Serum


Ordering Guidance


This test is the preferred test for patients previously tested for Streptococcus pneumoniae antibodies (as part of follow up testing or part of pre/post vaccine assessment).

 

The preferred test for patients being evaluated for possible immunodeficiency or for assessment of pneumococcal vaccination response (initial evaluation) is PNTOR / Streptococcus pneumoniae IgG Antibodies, Total, with Reflex, Serum.

 

The preferred test for patients previously tested for S pneumoniae serotypes (as part of follow up testing or part of pre/post vaccine assessment) is PN23M / Streptococcus pneumoniae IgG Antibodies, 23 Serotypes, Serum.



Specimen Required


Collection Container/Tube:

Preferred: Serum gel

Acceptable: Red top

Submission Container/Tube: Plastic vial

Specimen Volume: 0.5 mL

Collection Instructions: Centrifuge and aliquot serum into a plastic vial.


Useful For

Assessing the IgG antibody response to active immunization with nonconjugated 23-valent pneumococcal vaccines

 

Assessing the IgG antibody response to active immunization with conjugated 13-valent, 15-valent and 20-valent pneumococcal vaccines

 

Determining the ability of an individual to produce an antibody response to polysaccharide antigens, as part of an evaluation for humoral or combined immunodeficiencies

Reporting Name

S. pneumoniae IgG Ab, Total, S

Specimen Type

Serum

Specimen Minimum Volume

0.3 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Refrigerated (preferred) 21 days
  Frozen  21 days

Reject Due To

Gross hemolysis OK
Gross lipemia OK
Gross icterus OK
Heat-inactivated specimen Reject

Reference Values

≥9.7 mcg/mL

Day(s) Performed

Tuesday, Thursday

Report Available

2 to 8 days

Specimen Retention Time

12 weeks

Performing Laboratory

Mayo Clinic Laboratories in Rochester

CPT Code Information

86317

LOINC Code Information

Test ID Test Order Name Order LOINC Value
PNTO S. pneumoniae IgG Ab, Total, S 43236-9

 

Result ID Test Result Name Result LOINC Value
PNTO S. pneumoniae IgG Ab, Total, S 43236-9

Supportive Data

The utility of measuring the total IgG response to Streptococcus pneumoniae vaccination was assess in a study published by Parker et al. In a cohort of healthy individuals (n=77), a median 9-fold increase in IgG reactivity was observed 4 to 6 weeks after vaccination, with median IgG concentrations of 41 mcg/mL and 375 mcg/mL in pre- and post-vaccination samples, respectively. Based upon data in the healthy control group, a concentration of 77 mcg/mL was established as the threshold for defining a normal vaccination response. Using this cut-off, in a cohort of individuals with humoral primary immunodeficiencies, 62.7% (64/102) had results below this cut-off following vaccination, compared to 3.9% (3/77) in the healthy control group (10). While measurement of antibodies against Streptococcus pneumoniae is not diagnostic for any specific disease, it can be used to understand the nature and magnitude of immunoglobulin deficiencies in patients with suspected humoral immune disorders.